Killer flu recreated in the lab

Scientists have shown that tiny changes to modern flu viruses could render them as deadly as the 1918 strain which killed millions. A US team added two genes from a sample of the 1918 virus to a modern strain known to have no effect on mice. Animals exposed to this composite were dying within days of symptoms similar to those found in human victims of the 1918 pandemic. The research is published in the journal Nature.

“ The lesson is not to be complacent about anything to do with flu ”
Professor John Oxford

The work of the US team, lead by Dr Yoshihiro Kawaoka of the University of Wisconsin, was carried out under the tightest security. Experts focused on two genes thought to play a key role in the infection process. One controls production of a spike-like molecule called haemagglutinin (HA), believed to be used by the flu virus to attach itself to the cells it is about to infect. (Learn more from the BBC )

World Health Organization declares influenza A (H1N1) ’swine flu’ a pandemic

An emergency meeting of the World Health Organization (WHO) has ended by declaring the influenza A(H1N1) or “swine flu” outbreak a global pandemic.According to the world’s peak health body more than 28,000 cases of influenza A (H1N1) have been reported globally and over 141 confirmed deaths. In at least two regions of the world the virus is spreading, with rising cases being seen in the UK, Australia, Japan and Chile. One factor which prompted the move to a level six pandemic was that in the southern hemisphere, the virus seems to be crowding out normal seasonal influenza. Influenza A(H1N1) first emerged in Mexico in April and has since spread to 74 countries. (Learn more at)

Readying Americans for Dangerous, Mandatory Vaccinations
by Stephen Lendman

At least three US federal laws should concern all Americans and suggest what may be coming - mandatory vaccinations for hyped, non-existant threats, like H1N1 (Swine Flu). Vaccines and drugs like Tamiflu endanger human health but are hugely profitable to drug company manufacturers. The Project BioShield Act of 2004 (S. 15) became law on July 21, 2004 "to provide protections and countermeasures against chemical, radiological, or nuclear agents that may be used in a terrorist attack against the United States by giving the National Institutes of Health contracting flexibility, infrastructure improvements, and expediting the scientific peer review process, and streamlining the Food and Drug Administration approval process of countermeasures." ( Learn More at)